Hantech Bio-Technology Co (1294) Fair Value & Analysis
Consumer Defensive · TW · Market cap 2.0B TWD
Fair value as of: Jul 23, 2026
From 26 valuation models · updated 18 days ago
Fair value updated Jul 23, 2026, revised from 87.02 TWD to 72.52 TWD (−16.7%) since Jul 7, 2026. Share price −1.5% over the past month.
A solid business, screening 25% undervalued on our models.
What matters now
- Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality.
- Our model range runs from 53.58 TWD (bear) to 91.46 TWD (bull), base 72.52 TWD. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 62/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 23, 2026.
How to read this chart
46‑month range 19.23 TWD – 483.55 TWD · fair‑value band 53.58 TWD – 91.46 TWD · the 58.10 TWD price screens below the 72.52 TWD fair value. Dashed = 300-day average. As of Jul 23, 2026.
Analysis
Hantech Bio-Technology Co (1294) currently trades at 58.10 TWD, while our model-based Fair Value estimate is 72.52 TWD, implying the stock looks roughly 24.8% undervalued today. The Quality Score stands at 62/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Hantech Bio-Technology Co generated revenue of 832M TWD at a net margin of 18.0%. Revenue grew 30.6% year over year. It earns a return on equity of 17.6%. Net debt stands at 118M TWD. Fundamentals as of Jul 23, 2026
Our scenario range runs from 53.58 TWD (bear case) to 91.46 TWD (bull case); at 58.10 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 39% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 25%, 1294 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (124.21 TWD) versus Asset-Based (15.29 TWD). Highest evidence: Growth DCF (80).
Notify me when 1294 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 39
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Hantech Bio-Technology Co., Ltd., through its subsidiaries, engages in the manufacture, trade in, and distributes biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products in Taiwan and internationally. The company offers OEM & ODM manufacturer of liquid, jelly, and gel-type health supplements.
Full company description
Hantech Bio-Technology Co., Ltd., through its subsidiaries, engages in the manufacture, trade in, and distributes biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products in Taiwan and internationally. The company offers OEM & ODM manufacturer of liquid, jelly, and gel-type health supplements. It also provides aluminum foil bag designs; and aluminum foil-packaged beverage production activities. In addition, the company is involved in the manufacture of machinery and equipment; and trade in of health food raw materials. It serves clients across both online and offline channels, including direct sales, micro-businesses, physical stores (pharmacies/drugstores/beauty shops), TV, radio, telemarketing centers, TV shopping, online shopping, and live-stream shopping. Hantech Bio-Technology Co., Ltd. was founded in 2007 and is based in Changhua, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Hantech Bio-Technology Co reported revenue of 779M TWD in FY2025 versus 240M TWD in FY2021, a compound +34.2%/yr. Reported net income was 139M TWD in FY2025, compounding +43.8%/yr from FY2021.
Watch 1294: get an alert when its fair value changes →
Peer Group
Packaged Foods · 649 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Hantech Bio-Technology Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Hantech Bio-Technology Co (1294) overvalued or undervalued?
What is the fair value of 1294?
What is the quality score of 1294?
What is the revenue of Hantech Bio-Technology Co (1294)?
What is the net profit margin of 1294?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Hantech Bio-Technology Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.